A specific subset of SR proteins shuttles continuously between the nucleus and the cytoplasm

  1. Javier F. Cáceres1,3,4,
  2. Gavin R. Screaton2, and
  3. Adrian R. Krainer1,4
  1. 1Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724-2208 USA; 2Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford OX3 9DU, UK

Abstract

The SR proteins constitute a large family of nuclear phosphoproteins required for constitutive pre-mRNA splicing. These factors also have global, concentration-dependent effects on alternative splicing regulation and this activity is antagonized by members of the hnRNP A/B family of proteins. We show here that whereas some human SR proteins are confined to the nucleus, three of them—SF2/ASF, SRp20, and 9G8—shuttle rapidly and continuously between the nucleus and the cytoplasm. By swapping the corresponding domains between shuttling and nonshuttling SR proteins, we show that the carboxy-terminal arginine/serine-rich (RS) domain is required for shuttling. This domain, however, is not sufficient to promote shuttling of an unrelated protein reporter, suggesting that stable RNA binding mediated by the RNA-recognition motifs may be required for shuttling. Consistent with such a requirement, a double point-mutation in RRM1 of SF2/ASF that impairs RNA binding prevents the protein from shuttling. In addition, we show that phosphorylation of the RS domain affects the shuttling properties of SR proteins. These findings show that different SR proteins have unique intracellular transport properties and suggest that the family members that shuttle may have roles not only in nuclear pre-mRNA splicing but also in mRNA transport, cytoplasmic events, and/or processes that involve communication between the nucleus and the cytoplasm.

Keywords

Footnotes

  • 3 Present address: MRC Human Genetics Unit, Western General Hospital, Edinburgh EH4 2XU, UK.

  • 4 Corresponding authors.

  • E-MAIL krainer{at}cshl.org; FAX (516)-367-8453. E-MAILJavier.Caceres{at}hgu.mrc.ac.uk; FAX 44 131 343 2620.

    • Received July 17, 1997.
    • Accepted October 28, 1997.
| Table of Contents

Life Science Alliance